1. Epidermal growth factor attenuates blood‐spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury. Issue 6 (15th January 2016) Authors: Zheng, Binbin; Ye, Libing; Zhou, Yulong; Zhu, Sipin; Wang, Qingqing; Shi, Hongxue; Chen, Daqing; Wei, Xiaojie; Wang, Zhouguang; Li, Xiaokun; Xiao, Jian; Xu, Huazi; Zhang, Hongyu Journal: Journal of cellular and molecular medicine Issue: Volume 20:Issue 6(2016) Page Start: 1062 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and Bioequivalence of 2 Oral Formulations of Domperidone After Single‐Dose Administration in Healthy Chinese Subjects. Issue 9 (9th April 2022) Authors: Ye, Libing; Shen, Minmin; Chen, Yingrong; Li, Xiaofeng; Xu, Min; Yao, Chong; Yang, Shuixin Journal: Clinical pharmacology in drug development Issue: Volume 11:Issue 9(2022) Page Start: 1084 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. RAGE: A potential therapeutic target during FGF1 treatment of diabetes‐mediated liver injury. Issue 10 (31st March 2021) Authors: Zheng, Peipei; Tang, Zonghao; Xiong, Jun; Wang, Beini; Xu, Jingyu; Chen, Lulu; Cai, Shufang; Wu, Chengbiao; Ye, Libing; Xu, Ke; Chen, Zimiao; Wu, Yanqing; Xiao, Jian Journal: Journal of cellular and molecular medicine Issue: Volume 25:Issue 10(2021) Page Start: 4776 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗